Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 797, pseudogene (RNU6-797P) is a human genomic element that belongs to the set of U6 small nuclear RNA (snRNA) pseudogenes[1][3]. It is a processed pseudogene, not encoding a functional RNA or protein[3][2]. U6 small nuclear RNA genes, when functional, play a crucial role in the spliceosome machinery for mRNA splicing, but this specific pseudogene is a non-functional remnant generated most likely by retrotransposition mechanisms such as LINE-1 activity[2]. There is no evidence that this pseudogene acts as a therapeutic target or marker, nor that it is directly implicated in disease, drug action, or biomarker strategies. Pseudogenes in general are of evolutionary and genomic interest, sometimes modulating gene expression by acting as miRNA decoys or competing endogenous RNAs, but there are no records of RNU6-797P having such functions[4]. Its primary value currently lies in genome annotation and evolutionary studies rather than experimental therapeutics or diagnostics.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 797, pseudogene (RNU6-797P).